Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males

AIM: Clinical use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) is consistently associated with heart rate (HR) acceleration in type 2 diabetes patients. We explored the mechanisms underlying this potential safety concern. METHODS: Ten healthy overweight males (aged 20–27 years) were examin...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Clin Pharmacol
Prif Awduron: Smits, Mark M., Muskiet, Marcel H. A., Tonneijck, Lennart, Hoekstra, Trynke, Kramer, Mark H. H., Diamant, Michaela, van Raalte, Daniël H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2016
Pynciau:
Clinical Trials
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4799913/
https://ncbi.nlm.nih.gov/pubmed/26609792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12843
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg